JointMedica’s Polymotion Hip Resurfacing System Granted Breakthrough Device Designation

Exactech has announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion Hip Resurfacing System. Exactech, a minority shareholder of JointMedica Limited, is collaborating with the United...

Paragon 28 Expands Soft Tissue Portfolio

Paragon 28 Inc., a medical device company exclusively focused on the foot and ankle orthopedic market, has announced an expansion of its soft-tissue portfolio with the launch of its Grappler Suture Anchor System. The Grappler Suture Anchor System provides surgeons an...

National Medical Billing Services Acquires Medi-Corp Inc.

National Medical Billing Services, a health care revenue cycle management (RCM) company serving the surgical market, has acquired Medi-Corp Inc., a nationwide RCM services provider specializing in anesthesia, ASCs and pain management. “This partnership will further...

Ga. Governor Signs Surgical Smoke Legislation

Georgia Governor Brian P. Kemp recently signed several bills designed to benefit health care providers and patients in Georgia. The new laws will also strengthen the state's health care system, according to a news release. One piece of legislation signed into law by...

Steribin and Vioguard Announce Merger

Vioguard Cubby Plus, 360 degree UV-C disinfection box used in healthcare, hospitality, and education worldwide. Disinfect phones, tablets, name badges, pens, and much more.

Steribin F3, UV-C disinfection featuring pulsed UV light and a versatile conveyor belt. Model types available for security trays, food processing, packaging, and more.


Steribin Inc., the developer of the first UV disinfection device for airport security trays, and Vioguard Inc., a provider of hospital-grade UV disinfection solutions, announced the merger of the two companies. The merger took effect last week, and the companies will combine business operations through the first half of 2022.

The combined company will be privately held and operate under the name UV360 – this new brand equipped with deep technology resources, a range of UV disinfection solutions and a global customer base. Jon Cole, Steribin’s CEO, has been named the CEO of the combined company. Imagen Capital Partners, the majority stockholder of Vioguard will remain on the board of directors of UV360. Company operations will operate from southern Utah.

“Prior to 2020, the UV disinfection market saw years of steady growth, but the COVID-19 pandemic highlighted the urgent need for effective disinfection solutions in every sector,” said Cole. “With a combined 16 years between Steribin and Vioguard, UV360 has the experience necessary to push the boundaries of UV innovation while continuing our tradition of exceptional customer service.”



Submit a Comment

Your email address will not be published.